한국어
English
日本語
中文(简体)
Lenara Tablet (Letrozole)
2.5mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.
Letrozole is a hormone-modulating anticancer drug used in the treatment of breast cancer.
MFDS ingredient code M285465
Letrozole belongs to the class of aromatase inhibitors and is primarily used for the treatment of hormone-dependent breast cancer in postmenopausal women. This ingredient reduces the production of estrogen in the body, inhibiting the growth of cancer cells.
Letrozole blocks the enzyme aromatase, preventing the production of the female hormone estrogen. When estrogen levels decrease, hormone-dependent breast cancer cells are unable to grow.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other aromatase inhibitors, letrozole selectively inhibits only the aromatase enzyme, resulting in relatively fewer side effects. It is also particularly effective in postmenopausal women and can be used in combination with other hormone therapies.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.